ORPH.L Share News (ORPH)

ORPH.L Information

There is currently no data for ORPH

UK earnings, trading statements calendar - next 7 days

Tue, 31st May 2022 16:05

Wednesday 1 June
Impax Asset Management Group PLC	Half Year Results
Dr Martens PLC	Full Year Results
Thursday 2 June
no events scheduled
Friday 3 June
no events scheduled
Monday 6 June
Atrato Onsite Energy PLC	Half Year Results
Empiric Student Property PLC	Trading Statement
Jadestone Energy PLC	Full Year Results
Tuesday 7 June
Gooch & Housego PLC	Half Year Results
LXi REIT PLC	Full Year Results
NewRiver REIT PLC	Full Year Results
Open Orphan PLC	Full Year Results
Schroder Real Estate Investment Trust Ltd	Full Year Results

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News

17 Jan 2020 10:51

Open Orphan Takeover Of hVIVO Now Wholly Unconditional

16 Jan 2020 18:15

Open Orphan Readmitted To AIM Following Reverse Takeover Of hVIVO

14 Jan 2020 16:10

Open Orphan To Mount Compulsory Buyout To Get hVIVO Deal Over Line

6 Jan 2020 17:29

UPDATE: Open Orphan To Relist On AIM Following hVIVO All-Share Merger

6 Jan 2020 11:49

Open Orphan To Relist On AIM Following hVIVO All-Share Merger

6 Jan 2020 10:55

Open Orphan inks three-year contract with mystery European firm

(Sharecast News) - Drug consulting services platform Open Orphan has won a new three-year contract with an unnamed German pharmaceutical company.

31 Dec 2019 09:46

Open Orphan Meets Acceptance Condition For Merger With hVIVO

31 Dec 2019 06:31

UK Shareholder Meetings Calendar - Next 7 Days

18 Dec 2019 12:54

Open Orphan signs deal with US biopharmaceutical firm SFA

(Sharecast News) - Europe-focussed rare and orphan drug consulting service provider Open Orphan announced the signing of a contract with SFA Therapeutics, a biopharmaceutical company based in Pennsylvania, on Wednesday.

18 Dec 2019 12:29

Open Orphan Unit To Assist SFA Therapeutics In Filing Drug Application

9 Dec 2019 14:36

Open Orphan agrees acquisition of hVIVO at 34% premium

(Sharecast News) - Open Orphan, the rare and orphan drug services company, has agreed the takeover of hVIVO by means of an all-share reverse take-over at a 33.8% premium.

9 Dec 2019 11:23

AIM-Listed Firms Open Orphan And hVIVO Set For Tie-Up

25 Nov 2019 14:57

Open Orphan Signs Five Companies For Genomic Health DataBANK Platform

18 Nov 2019 10:35

Open Orphan Teams With Carna For Human Clinical Pharmacology Trial

18 Nov 2019 09:58

Open Orphan signs pharmacology trial contract with Carna

(Sharecast News) - Rare and orphan drug consulting services provider Open Orphan announced the signing of a contract with Carna Bioscience for a first-in-human clinical pharmacology trial, it announced on Monday.

Latest Share Chat

ORPH.L Share News (ORPH)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Login to your account

Quickpicks are a member only feature

Login to your account